Johannes Grosse

Johannes Grosse

Company: Vir Biotechnologies

Job title: Senior Director, Drug Discovery

Seminars:

Speaker Q&A 2:40 pm

Read more

day: Day Two

Cross talk between STING, RIG-I and purinergic signaling. 1:50 pm

A successful resolution of an encounter with a pathogen depends on a response finetuned in strength and duration. As pathogens often activate several pattern recognition receptors during invasion and intracellular steps of their life cycle the cross talk between signaling pathways is essential for that tuning and termination of the response. In addition, paracrine signals…Read more

day: Day Two

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.